Intuitive ISRG announced that the FDA has cleared the integration of mobile cone-beam CT (CBCT) imaging technology with its minimally-invasive, robotic-assisted bronchoscopy system, Ion Endoluminal System. The company is integrating Siemens Healthineers’ Cios Spin mobile imaging, a CBCT imaging technology, with its robotic bronchoscopy or lung-biopsy system.
Intuitive’s Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform, which was approved by the FDA in 2019, expanding the company’s services into diagnostic and endoluminal procedures. The system allows biopsy of small and difficult-to-access lesions in the lung as well as biopsy of peripheral lung and provides the stability necessary for precision in a biopsy.
The integration of Siemens Healthineers’ Cios Spin mobile imaging will allow Intuitive to offer 2D and 3D imaging that will help improve biopsy tool placement, leading to better diagnostic yield. The 3D imaging will specially help physicians to place biopsy tools appropriately in a suspicious nodule in the peripheral lung.
Data from early studies on Ion Endoluminal System have demonstrated a diagnostic yield of approximately 80%, with a relatively small average nodule size. Data from an initial single-center study showed that the integration of Cios Spin has the potential to improve the diagnostic yield by up to approximately 10%. A better diagnostic yield will lead to better prognosis and effective treatment options.
Intuitive believes that the new imaging integration could help improve the accuracy of biopsy procedures, a key step to diagnose lung cancer that kills more people annually than any other cancer. Early detection has the potential to improve the survival rates of lung cancer patients. The company’s integration of Cios Spin with its robotic bronchoscopy system is likely to accelerate lung biopsy with more accuracy.
The company is currently focusing on the potential inclusion of other technology collaborators to enhance its ecosystem as part of its goal to make the Ion Endoluminal System a standard of care for lung biopsy.
The installed base of Ion Endoluminal System has gained significantly since its approval. Intuitive’s integration of a mobile imaging technology and focus on enhancing the ecosystem will likely help it to sustain the growth rate.
Shares of Intuitive have declined 44.1% so far this year compared with the industry’s decrease of 30.5%.
Image Source: Zacks Investment Research
Apart from the Ion Endoluminal System, Intuitive has another robotic system that allows minimally-invasive surgical procedures called da Vinci Surgical systems. The system allows 3D imaging that helps surgeons to overcome many of the limitations of traditional open surgery. The da Vinci Surgical system is the leading revenue-generator for the company. The company’s first-quarter revenues were primarily driven by strong growth in da Vinci procedure volume as well as a higher shipment of the system.
Although Intuitive’s top line demonstrated robust growth in the first quarter, the rising COVID-19 infections are a concern as they may hurt patient visits to physicians as well as shipments of surgical and diagnostic systems. Per management, the COVID-19 resurgence impacted the company’s procedure volume in the first quarter.
Intuitive Surgical, Inc. price | Intuitive Surgical, Inc. Quote
Intuitive currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked biotech stocks are AMN Healthcare Services AMN, Masimo MASI and Aspira Women's Health AWH. While AMN Healthcare sports a Zacks Rank #1, Masimo and Aspira Women's Health carry a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for AMN Healthcare’s 2022 earnings per share has improved from $9.31 to $10.46 in the past 60 days. Shares of AMN have declined 10.3% year to date.
Earnings of AMN Healthcare beat estimates in each of the last four quarters, the average being 15.6%.
The Zacks Consensus Estimate for Masimo’s 2022 earnings has increased from $4.29 to $4.61 per share in the past 60 days. Shares of MASI have declined 55.4% in the year-to-date period.
Earnings of Masimo beat estimates in each of the last four quarters, the average surprise being 4.42%.
The Zacks Consensus Estimate for Aspira Women's Health’s 2022 loss has narrowed from 33 cents to 30 cents per share in the past 60 days. Shares of AWH have declined 66.8% in the year-to-date period.
Earnings of Aspira Women's Health beat estimates in one of the last four quarters, missed the mark once and met twice, the average negative surprise being 0.35%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report Masimo Corporation (MASI) : Free Stock Analysis Report AMN Healthcare Services Inc (AMN) : Free Stock Analysis Report Aspira Women's Health Inc. (AWH) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Being patient doesn't always pay off.
The Senior Citizen’s League says there ‘may be no COLA payable in 2024.'
Currently, AT&T sports a high 7.4% dividend yield, which means the company will pay an estimated 7.4% of its stock price to shareholders each year. This number constantly fluctuates because it is calculated using the annual dividend payout divided by the stock price. The yield rises if the dividend goes up and the stock price stays the same.
Sales tax on large purchases, like a car, is crucial to factor into the price. Depending on where you live and the price of your car, sales tax can cost you thousands of dollars. But did you know there are … Continue reading → The post How to Legally Avoid Paying Sales Tax on a Used Car appeared first on SmartAsset Blog.
The economist warned in 2006 that the U.S. housing bust would cause a financial crisis. Now he has a new economic doomsday prediction, and it isn't pretty.
The chart, from Redfin, shows how higher mortgage rates and a pullback in buyer demand, has forced sellers to cut prices to entice bids.
Investors seemingly can’t stop trying to pick a stock market bottom, no matter how bad the news—and it continues to backfire. Consider: This past Thursday, September’s consumer inflation report came in much hotter than expected, with the core CPI hitting a 40-year high. The initial response was exactly what you’d expect—the traded down as much as 2.4%—but then it started rallying…and rallying.
(Bloomberg) -- Tesla Inc. shares tumbled about 50% from their all-time high, amid a broader selloff in the US stock market that has hit growth and technology companies especially hard. Most Read from BloombergRolex Prices to Drop Further as Supply Surges: Morgan StanleyPutin Tried for Years to Stop His Military From Using Western Parts — And Mostly FailedWorld Faces New Threats From Fast-Mutating Omicron VariantsA $25 Billion Grocery Deal Takes Fight to WalmartUndervalued US Stocks Could Soar 30
Everyone is hoping the market might be bottoming and by the recent actions of Bank of America clients, some evidently think the lows must be in sight. Last week, BofA customers splashed out $6.1 billion on US stocks, in what amounted to the third largest inflow since 2008. While the bank has stated it is not as confident the bottom is quite so close, it’s not hard to see why investors feel the time is right to lean into equities. The widespread losses have left scores of beaten-down stocks looki
The U.S. Treasury Department put an item on its agenda Friday to start talking with primary dealers about the potential for it to buy back some of its older debt to help keep markets functioning smoothly.
These diversified natural-resource giants have solid balance sheets, earnings, and dividends. All that they need is a rebound in commodity prices.
It's never a dull time analyzing Tesla's (NASDAQ: TSLA) stock. The innovative electric car company always seems to have something interesting going on. In this video, I take a beginner-friendly walk-through of Tesla's second-quarter earnings transcript.
Investors have become more confident that the company can put the past behind it as demand for air travel recovers.
Investors were surprised by the big rally in the stock market on Thursday, but Friday brought another dose of reality and disappointment. After having posted monumental gains despite high readings on inflation, the Nasdaq Composite (NASDAQINDEX: ^IXIC) closed at its worst level of the year, and the S&P 500 (SNPINDEX: ^GSPC) and Dow Jones Industrial Average (DJINDICES: ^DJI) gave up most of their advances from earlier in the week. One of the biggest stock stories of the past several years has been Tesla (NASDAQ: TSLA).
Nikola (NKLA) founder Trevor Milton was found guilty of three counts of criminal fraud on Friday in a case accusing him of spreading lies about the electric truck startup for his own personal benefit.
Yahoo Finance Live anchors discuss the dip in stock for Tesla amid CEO Elon Musk’s ongoing Twitter trial
It’s not just snow and smog you have to worry about in these locations.
In the midst of a bear market, with rising interest rates and the threat of a prolonged recession in the air, real estate investment trust (REIT) stocks have endured tremendous price declines. Given this, it isn’t easy to find REITs that could see dividend increases soon. Two questions come to mind. Why would a company raise its dividend when the yield is already increasing with each drop in price? And how do you find REITs with the dividend well-covered by funds from operations (FFO) and with s
(Bloomberg) -- Inflation shows few signs of cooling in the economy. The same cannot be said of markets, which are starting to seem like the only thing the Federal Reserve has going for it these days.Most Read from BloombergRolex Prices to Drop Further as Supply Surges: Morgan StanleyPutin Tried for Years to Stop His Military From Using Western Parts — And Mostly FailedWorld Faces New Threats From Fast-Mutating Omicron VariantsA $25 Billion Grocery Deal Takes Fight to WalmartUndervalued US Stocks
It's easy to see what makes investors so interested in this high-yield stock, but there are concerns.